|
G
|
Apob
|
apolipoprotein B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:18076041 |
RGD:2325763 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G
|
LOC101969148
|
cytochrome P450 1A1
|
|
ISO
|
DNA:polymorphism:exon:rs2606345 (human)
|
RGD |
PMID:19168589 |
RGD:2317210 |
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G
|
Ppard
|
peroxisome proliferator activated receptor delta
|
|
ISO
|
|
RGD |
PMID:18497548 |
RGD:2324871 |
NCBI chrNW_004936476:23,799,285...23,886,606
Ensembl chrNW_004936476:23,811,641...23,828,176
|
|
|
G
|
Ddr2
|
discoidin domain receptor tyrosine kinase 2
|
disease_progression
|
ISO
|
|
RGD |
PMID:29043607 |
RGD:150429712 |
NCBI chrNW_004936831:799,948...946,139
Ensembl chrNW_004936831:865,965...946,139
|
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
disease_progression
|
ISO
|
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G
|
Apob
|
apolipoprotein B
|
susceptibility
|
ISO
|
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human)
|
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO
|
DNA:SNP:intron:rs440446 (human)
|
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G
|
Atm
|
ATM serine/threonine kinase
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
|
|
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G
|
Mlh1
|
mutL homolog 1
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936473:26,556,636...26,600,830
Ensembl chrNW_004936473:26,556,611...26,603,736
|
|
G
|
Msh2
|
mutS homolog 2
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:25741868 PMID:33357406 |
|
NCBI chrNW_004936508:4,943,987...5,013,356
Ensembl chrNW_004936508:4,944,007...5,013,356
|
|
G
|
Palb2
|
partner and localizer of BRCA2
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823 |
|
NCBI chrNW_004936501:8,246,927...8,273,258
|
|
G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
|
|
NCBI chrNW_004936694:1,923,383...1,958,160
Ensembl chrNW_004936694:1,930,621...1,957,179
|
|
G
|
Pold1
|
DNA polymerase delta 1, catalytic subunit
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936889:231,373...250,985
Ensembl chrNW_004936889:231,373...250,987 Ensembl chrNW_004936889:231,373...250,987
|
|
G
|
Stk11
|
serine/threonine kinase 11
|
|
ISO
|
ClinVar Annotator: match by term: Bile duct cancer
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654
|
|
G
|
Tjp1
|
tight junction protein 1
|
|
ISO
|
protein:decreased expression:bile duct
|
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chrNW_004936483:1,814,870...2,045,802
Ensembl chrNW_004936483:1,814,894...2,030,946
|
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
disease_progression
|
ISO
|
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
susceptibility
|
ISO
|
DNA:polymorphism:exon:c.3972C>T (human)
|
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G
|
Adrb2
|
adrenoceptor beta 2
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
ISO
|
protein:increased expression:bile duct
|
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G
|
Anxa2
|
annexin A2
|
disease_progression
|
ISO
|
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chrNW_004936471:21,274,112...21,329,286
Ensembl chrNW_004936471:21,274,027...21,329,503
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
|
ISO
|
DNA:loss of heterozygosity DNA:hypermethylation:promoter
|
RGD |
PMID:10212000 PMID:15467712 |
RGD:2317198 RGD:2317205 |
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G
|
Apoa1
|
apolipoprotein A1
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G
|
Arid1a
|
AT-rich interaction domain 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24185509 |
|
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G
|
Asph
|
aspartate beta-hydroxylase
|
|
ISO
|
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chrNW_004936496:11,604,992...11,815,680
Ensembl chrNW_004936496:11,604,680...11,816,852
|
|
G
|
Atg101
|
autophagy related 101
|
disease_progression
|
ISO
|
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004936512:9,518,128...9,525,986
Ensembl chrNW_004936512:9,518,074...9,526,961
|
|
G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G
|
Birc6
|
baculoviral IAP repeat containing 6
|
ameliorates
|
ISO
|
mRNA:increased expression:bile duct (human)
|
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004936493:903,295...1,115,434
Ensembl chrNW_004936493:899,961...1,115,493
|
|
G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
ISO
|
DNA:missense mutation:cds:p.V600E (human)
|
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G
|
Cxcr1
|
C-X-C motif chemokine receptor 1
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936569:715,129...716,187
Ensembl chrNW_004936569:715,129...716,181
|
|
G
|
Egf
|
epidermal growth factor
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936563:1,058,803...1,181,393
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G
|
Epo
|
erythropoietin
|
|
ISO
|
mRNA, protein:increased expression:liver
|
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G
|
Epor
|
erythropoietin receptor
|
|
ISO
|
mRNA, protein:increased expression:liver
|
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004936659:1,468,391...1,473,880
Ensembl chrNW_004936659:1,468,634...1,473,880
|
|
G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16818635 |
|
NCBI chrNW_004936490:14,887,062...14,910,038
Ensembl chrNW_004936490:14,887,043...14,909,956
|
|
G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
disease_progression no_association
|
ISO
|
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human)
|
RGD |
PMID:24179546 |
RGD:126779604 |
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G
|
Faslg
|
Fas ligand
|
|
ISO
|
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26258846 |
|
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G
|
Fscn1
|
fascin actin-bundling protein 1
|
disease_progression
|
ISO
|
protein:increased expression:bile ducts
|
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chrNW_004936765:609,894...619,417
Ensembl chrNW_004936765:609,861...619,456
|
|
G
|
Gstp1
|
glutathione S-transferase pi 1
|
treatment
|
ISO
|
human cell line in a mouse model DNA:hypermethylation:promoter
|
RGD |
PMID:12805482 PMID:15467712 |
RGD:14401711 RGD:2317198 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G
|
Hdac6
|
histone deacetylase 6
|
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chrNW_004936721:757,500...778,416
Ensembl chrNW_004936721:758,181...778,053
|
|
G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
mRNA, protein:increased expression: : protein:increased expression:serum
|
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317909 RGD:2317925 |
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G
|
Hnf1b
|
HNF1 homeobox B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:39887605 |
|
NCBI chrNW_004936490:649,551...702,448
Ensembl chrNW_004936490:649,546...702,672
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24185509 |
|
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24185509 |
|
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G
|
Il10
|
interleukin 10
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G
|
Il19
|
interleukin 19
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936557:5,765,093...5,769,853
Ensembl chrNW_004936557:5,765,093...5,769,853
|
|
G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G
|
Il1r2
|
interleukin 1 receptor type 2
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936713:679,680...716,801
Ensembl chrNW_004936713:701,155...716,650
|
|
G
|
Il4r
|
interleukin 4 receptor
|
|
ISO
|
mRNA:increased expression:bile duct
|
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
|
|
G
|
Il6
|
interleukin 6
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G
|
Ins
|
insulin
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
G
|
Kcnd2
|
potassium voltage-gated channel subfamily D member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34418280 |
|
NCBI chrNW_004936605:4,370,222...4,828,972
Ensembl chrNW_004936605:4,372,671...4,825,423
|
|
G
|
Kit
|
KIT proto-oncogene, receptor tyrosine kinase
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936482:17,162,854...17,238,319
Ensembl chrNW_004936482:17,162,950...17,238,274
|
|
G
|
Kmt2c
|
lysine methyltransferase 2C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561520 |
|
NCBI chrNW_004936527:7,310,885...7,508,032
Ensembl chrNW_004936527:7,312,721...7,506,365
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G
|
Krt7
|
keratin 7
|
|
ISO
|
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chrNW_004936512:9,641,587...9,656,573
Ensembl chrNW_004936512:9,641,587...9,656,524
|
|
G
|
LOC101957714
|
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
|
|
ISO
|
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human)
|
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chrNW_004936514:1,467,460...1,480,185
Ensembl chrNW_004936514:1,467,261...1,480,185
|
|
G
|
LOC101963142
|
mucin-3B
|
|
ISO
|
mRNA:decreased expression:bile duct
|
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936543:886,333...904,504
|
|
G
|
LOC101964975
|
interleukin-8
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G
|
LOC101971027
|
neuroendocrine secretory protein 55
|
disease_progression
|
ISO
|
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17356712 PMID:22561520 |
RGD:1601377 |
NCBI chrNW_004936530:1,353,432...1,407,437
|
|
G
|
Mdm2
|
MDM2 proto-oncogene
|
disease_progression
|
ISO
|
protein:increased expression:intrahepatic bile duct (human)
|
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chrNW_004936545:6,709,903...6,732,334
|
|
G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
disease_progression
|
ISO
|
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat)
|
RGD |
PMID:14656942 PMID:16818635 |
RGD:2317578 RGD:2317601 |
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G
|
Mfsd4a
|
major facilitator superfamily domain containing 4A
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936557:6,823,771...6,852,534
Ensembl chrNW_004936557:6,823,597...6,842,741
|
|
G
|
Mgmt
|
O-6-methylguanine-DNA methyltransferase
|
|
ISO
|
DNA:hypermethylation:promoter (human)
|
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chrNW_004936486:16,744,607...16,923,209
Ensembl chrNW_004936486:16,744,570...16,923,543
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
disease_progression
|
ISO
|
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chrNW_004936486:15,561,327...15,587,109
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
disease_progression
|
ISO
|
protein:increased expression:bile duct
|
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667 RGD:2325769 |
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
protein:increased expression:bile duct mRNA:increased expression:bile duct
|
RGD |
PMID:15213623 PMID:16463672 |
RGD:2324667 RGD:2325856 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
susceptibility
|
ISO
|
DNA:polymorphism (human)
|
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G
|
Muc1
|
mucin 1, cell surface associated
|
disease_progression
|
ISO
|
protein:increased secretion:bile protein:increased expression:bile duct: protein:increased expression:serum mRNA:increased expression:bile duct
|
RGD |
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217 |
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G
|
Muc16
|
mucin 16, cell surface associated
|
|
ISO
|
associated with Opisthorchiasis;protein:increased expression:serum
|
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chrNW_004936588:5,506,683...5,586,450
|
|
G
|
Muc2
|
mucin 2, oligomeric mucus/gel-forming
|
|
ISO
|
mRNA:decreased expression:bile duct
|
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936816:60,499...91,628
Ensembl chrNW_004936816:60,499...91,628
|
|
G
|
Muc4
|
mucin 4, cell surface associated
|
disease_progression
|
ISO
|
protein:increased expression:bile duct
|
RGD |
PMID:14752841 PMID:19082442 |
RGD:2303602 RGD:2324944 |
NCBI chrNW_004936784:515,608...539,915
|
|
G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
disease_progression
|
ISO
|
protein:increased expression:serum mRNA:increased expression:bile duct
|
RGD |
PMID:11680592 PMID:14508831 |
RGD:2324948 RGD:2324990 |
NCBI chrNW_004936816:129,926...159,396
|
|
G
|
Muc5b
|
mucin 5B, oligomeric mucus/gel-forming
|
|
ISO
|
mRNA:decreased expression:bile duct
|
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936816:174,943...209,241
|
|
G
|
Muc6
|
mucin 6, oligomeric mucus/gel-forming
|
|
ISO
|
protein:increased expression: :
|
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chrNW_004936816:882...14,717
|
|
G
|
Ncam1
|
neural cell adhesion molecule 1
|
|
ISO
|
associated with hepatitis
|
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chrNW_004936612:1,262,557...1,556,281
Ensembl chrNW_004936612:1,262,544...1,556,016
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16094703 PMID:16818635 |
RGD:2325280 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G
|
Notch1
|
notch receptor 1
|
|
ISO
|
protein:increased expression:cholangiocyte
|
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chrNW_004936669:1,292,016...1,334,061
Ensembl chrNW_004936669:1,292,088...1,332,428
|
|
G
|
Nr1h4
|
nuclear receptor subfamily 1 group H member 4
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver (rat)
|
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chrNW_004936492:13,315,265...13,365,186
Ensembl chrNW_004936492:13,315,265...13,374,034
|
|
G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
disease_progression
|
ISO
|
DNA:loss of heterozygosity (human)
|
RGD |
PMID:11260864 PMID:11866974 |
RGD:2317134 RGD:2317136 |
NCBI chrNW_004936602:3,411,106...3,418,826
Ensembl chrNW_004936602:3,413,282...3,418,831
|
|
G
|
Osbp2
|
oxysterol binding protein 2
|
|
ISO
|
mRNA:increased expression:blood
|
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004936755:31,113...120,747
Ensembl chrNW_004936755:31,009...121,887
|
|
G
|
Osbpl7
|
oxysterol binding protein like 7
|
|
ISO
|
mRNA:increased expression:blood
|
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004936490:13,491,704...13,506,742
Ensembl chrNW_004936490:13,491,544...13,506,768
|
|
G
|
Panx2
|
pannexin 2
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936629:618,758...626,446
Ensembl chrNW_004936629:618,042...626,452
|
|
G
|
Pawr
|
pro-apoptotic WT1 regulator
|
|
ISO
|
mRNA,protein:decreased expression:cholangiocyte:
|
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chrNW_004936698:650,225...746,593
Ensembl chrNW_004936698:650,953...747,057
|
|
G
|
Pbrm1
|
polybromo 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24185509 |
|
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G
|
Peg3
|
paternally expressed 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561520 |
|
NCBI chrNW_004936882:577,424...607,691
Ensembl chrNW_004936882:577,395...591,042
|
|
G
|
Pes1
|
pescadillo ribosomal biogenesis factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34845814 |
|
NCBI chrNW_004936904:125,922...140,559
Ensembl chrNW_004936904:126,003...140,235
|
|
G
|
Pir
|
pirin
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936470:4,794,803...4,902,211
Ensembl chrNW_004936470:4,793,823...4,902,471
|
|
G
|
Ppia
|
peptidylprolyl isomerase A
|
ameliorates
|
ISO
|
human cell line and construct in a mouse model
|
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chrNW_004936478:19,669,727...19,673,355
Ensembl chrNW_004936478:19,669,506...19,673,398
|
|
G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936520:1,987,989...2,146,473
Ensembl chrNW_004936520:1,987,045...2,146,540
|
|
G
|
Prex2
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
|
sexual_dimorphism
|
ISO
|
DNA:substitutions, insertion/deletions: (human)
|
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chrNW_004936496:6,005,410...6,284,332
Ensembl chrNW_004936496:6,008,277...6,284,346
|
|
G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26258846 |
|
NCBI chrNW_004936659:2,750,015...2,765,914
Ensembl chrNW_004936659:2,750,537...2,765,753
|
|
G
|
Prkacb
|
protein kinase cAMP-activated catalytic subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26258846 |
|
NCBI chrNW_004936608:1,353,905...1,464,636
Ensembl chrNW_004936608:1,353,897...1,464,636
|
|
G
|
Prrg4
|
proline rich and Gla domain 4
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936533:5,032,718...5,053,452
Ensembl chrNW_004936533:5,032,581...5,053,529
|
|
G
|
Prss56
|
serine protease 56
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936525:4,568,854...4,574,332
Ensembl chrNW_004936525:4,568,802...4,574,396
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:23376645 PMID:27022031 |
RGD:12802341 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
|
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G
|
Rassf8
|
Ras association domain family member 8
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936548:1,353,237...1,444,176
Ensembl chrNW_004936548:1,352,902...1,444,202
|
|
G
|
Reg1a
|
regenerating family member 1 alpha
|
susceptibility
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:11343228 |
RGD:10044031 |
NCBI chrNW_004936556:4,873,331...4,875,608
Ensembl chrNW_004936556:4,873,331...4,875,608
|
|
G
|
Rnf39
|
ring finger protein 39
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936723:967,376...972,496
Ensembl chrNW_004936723:967,263...975,952
|
|
G
|
Rnf43
|
ring finger protein 43
|
exacerbates
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human)
|
CTD RGD |
PMID:22561520 |
RGD:151361227 |
NCBI chrNW_004936490:4,660,904...4,742,669
Ensembl chrNW_004936490:4,683,725...4,741,828
|
|
G
|
Robo2
|
roundabout guidance receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561520 |
|
NCBI chrNW_004936505:5,544,011...6,747,417
Ensembl chrNW_004936505:5,548,164...6,094,225
|
|
G
|
Runx3
|
RUNX family transcription factor 3
|
|
ISO
|
protein:decreased expression:bile duct
|
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chrNW_004936474:9,751,946...9,802,910
Ensembl chrNW_004936474:9,751,946...9,802,910
|
|
G
|
Slc4a4
|
solute carrier family 4 member 4
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936598:3,391,587...3,713,629
Ensembl chrNW_004936598:3,391,575...3,713,635
|
|
G
|
Slc5a5
|
solute carrier family 5 member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17408651 |
|
NCBI chrNW_004936596:3,176,009...3,188,637
Ensembl chrNW_004936596:3,177,422...3,188,637
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
treatment disease_progression
|
ISO
|
|
RGD |
PMID:24131658 PMID:25475870 PMID:28347255 |
RGD:151361214 RGD:151361287 RGD:151361294 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G
|
Smad4
|
SMAD family member 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561520 |
|
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G
|
Socs3
|
suppressor of cytokine signaling 3
|
severity
|
ISO
|
protein:decreased expression:bile duct (human)
|
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004936594:2,932,297...2,935,358
Ensembl chrNW_004936594:2,933,747...2,934,451
|
|
G
|
Sox17
|
SRY-box transcription factor 17
|
severity
|
ISO
|
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004936496:1,248,582...1,251,406
Ensembl chrNW_004936496:1,248,577...1,251,430
|
|
G
|
Sox2
|
SRY-box transcription factor 2
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936566:1,630,698...1,632,607
Ensembl chrNW_004936566:1,631,822...1,632,613
|
|
G
|
Tgfb1
|
transforming growth factor beta 1
|
disease_progression
|
ISO
|
protein:increased expression:pancreas
|
RGD |
PMID:12632524 PMID:16083599 |
RGD:1299231 RGD:2325020 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G
|
Tgfbr2
|
transforming growth factor beta receptor 2
|
|
ISO
|
mRNA:increased expression:bile duct
|
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chrNW_004936473:21,324,669...21,409,430
Ensembl chrNW_004936473:21,324,658...21,409,430
|
|
G
|
Thbs1
|
thrombospondin 1
|
disease_progression
|
ISO
|
DNA:hypermethylation (human)
|
RGD |
PMID:11927969 PMID:12213730 PMID:16465407 |
RGD:2325024 RGD:2325026 RGD:2325027 |
NCBI chrNW_004936471:3,064,466...3,081,125
Ensembl chrNW_004936471:3,064,422...3,081,949
|
|
G
|
Tnc
|
tenascin C
|
severity
|
ISO
|
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004936487:4,172,263...4,256,780
Ensembl chrNW_004936487:4,172,886...4,233,126
|
|
G
|
Tnfaip3
|
TNF alpha induced protein 3
|
severity
|
ISO
|
protein:increased expression:bile duct (human)
|
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004936560:5,124,955...5,138,988
Ensembl chrNW_004936560:5,128,843...5,138,345
|
|
G
|
Tp53
|
tumor protein p53
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G
|
Ttr
|
transthyretin
|
|
ISO
|
protein:decreased expression:blood serum (human)
|
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chrNW_004936682:1,628,489...1,635,495
Ensembl chrNW_004936682:1,628,341...1,635,566
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
ClinVar Annotator: match by term: Cholangiocarcinoma
|
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G
|
Wdhd1
|
WD repeat and HMG-box DNA binding protein 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chrNW_004936697:129,821...184,238
Ensembl chrNW_004936697:130,105...183,576
|
|
G
|
Wnt9a
|
Wnt family member 9A
|
disease_progression
|
ISO
|
mRNA:altered expression:liver (human)
|
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936864:216,381...245,885
Ensembl chrNW_004936864:239,651...244,312
|
|
|
G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G
|
Pbrm1
|
polybromo 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G
|
Rac1
|
Rac family small GTPase 1
|
|
ISO
|
protein:increased expression:mucosa (human)
|
RGD |
PMID:21537609 |
RGD:153350126 |
NCBI chrNW_004936750:107,689...122,679
Ensembl chrNW_004936750:107,689...122,676
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
disease_progression
|
ISO
|
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
|
ISO
|
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936694:1,923,383...1,958,160
Ensembl chrNW_004936694:1,930,621...1,957,179
|
|
G
|
Pold1
|
DNA polymerase delta 1, catalytic subunit
|
|
ISO
|
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
|
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936889:231,373...250,985
Ensembl chrNW_004936889:231,373...250,987 Ensembl chrNW_004936889:231,373...250,987
|
|
G
|
Xpo1
|
exportin 1
|
disease_progression
|
ISO
|
protein:increased expression:extrahepatic bile duct (human)
|
RGD |
PMID:27279267 |
RGD:151665800 |
NCBI chrNW_004936491:6,921,753...6,962,062
Ensembl chrNW_004936491:6,921,319...6,962,343
|
|
|
G
|
Cdk1
|
cyclin dependent kinase 1
|
|
ISO
|
protein:increased expression:gallbladder
|
RGD |
PMID:15017593 |
RGD:2722465 |
NCBI chrNW_004936614:2,300,682...2,313,611
Ensembl chrNW_004936614:2,300,513...2,313,624
|
|
G
|
Ddr2
|
discoidin domain receptor tyrosine kinase 2
|
disease_progression
|
ISO
|
|
RGD |
PMID:29043607 |
RGD:150429712 |
NCBI chrNW_004936831:799,948...946,139
Ensembl chrNW_004936831:865,965...946,139
|
|
G
|
LOC101968921
|
angiotensin-converting enzyme
|
|
ISO
|
DNA:polymorphism: :rs4646994 (human)
|
RGD |
PMID:20438364 |
RGD:2325207 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
disease_progression
|
ISO
|
DNA:SNP::rs11954856(human)
|
RGD |
PMID:26715268 |
RGD:151356500 |
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G
|
Apob
|
apolipoprotein B
|
susceptibility
|
ISO
|
DNA:SNP: :rs693 (human)
|
RGD |
PMID:17696941 PMID:20082485 |
RGD:2325761 RGD:2325764 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO
|
DNA:SNP:intron:rs440446 (human)
|
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G
|
Axin2
|
axin 2
|
disease_progression
|
ISO
|
DNA:SNP::s4791171(human)
|
RGD |
PMID:26715268 |
RGD:151356500 |
NCBI chrNW_004936541:7,155,963...7,242,466
Ensembl chrNW_004936541:7,211,985...7,242,470
|
|
G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
|
|
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
ISO
|
mRNA:increased expression:gallbladder
|
RGD |
PMID:18497548 |
RGD:2324871 |
NCBI chrNW_004936471:3,631,760...3,696,024
Ensembl chrNW_004936471:3,633,536...3,695,684
|
|
G
|
Calr
|
calreticulin
|
exacerbates
|
ISO
|
mRNA, protein:increased expression:gall bladder (human)
|
RGD |
PMID:33591948 |
RGD:150521682 |
NCBI chrNW_004936659:1,994,695...1,999,070
Ensembl chrNW_004936659:1,994,648...1,999,430
|
|
G
|
Ctnnb1
|
catenin beta 1
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
PMID:10435629 PMID:26822237 |
|
NCBI chrNW_004936473:29,999,542...30,034,610
Ensembl chrNW_004936473:29,999,562...30,038,293
|
|
G
|
Dpyd
|
dihydropyrimidine dehydrogenase
|
disease_progression
|
ISO
|
|
RGD |
PMID:16619549 |
RGD:2317631 |
NCBI chrNW_004936537:1,660,461...2,439,305
Ensembl chrNW_004936537:1,660,477...2,439,273
|
|
G
|
Egf
|
epidermal growth factor
|
susceptibility
|
ISO
|
DNA:SNP: :+61A>G (rs4444903)(human)
|
RGD |
PMID:8093356 PMID:18571008 |
RGD:2317641 RGD:2317646 |
NCBI chrNW_004936563:1,058,803...1,181,393
|
|
G
|
Gli1
|
GLI family zinc finger 1
|
disease_progression
|
ISO
|
DNA:SNP::rs2228226(human)
|
RGD |
PMID:26715268 |
RGD:151356500 |
NCBI chrNW_004936646:1,622,308...1,629,787
Ensembl chrNW_004936646:1,622,308...1,629,779
|
|
G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
exacerbates
|
ISO
|
protein:increased expression:gall bladder (human)
|
RGD |
PMID:26318166 |
RGD:11528126 |
NCBI chrNW_004936659:1,890,786...1,892,619
Ensembl chrNW_004936659:1,891,080...1,892,123
|
|
G
|
Keap1
|
kelch like ECH associated protein 1
|
|
ISO
|
DNA:missense mutations, frameshift mutations:cds:multiple (human)
|
RGD |
PMID:18692501 |
RGD:6893398 |
NCBI chrNW_004936659:785,059...793,775
Ensembl chrNW_004936659:782,340...793,688
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:17704260 PMID:25741868 PMID:26242988 PMID:28492532 PMID:31666701 PMID:35658005 More...
|
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G
|
LOC101969148
|
cytochrome P450 1A1
|
|
ISO
|
DNA:transition: :6235T>C (human) DNA:polymorphism: :p.I462V (human)
|
RGD |
PMID:18287863 PMID:18990008 |
RGD:2317211 RGD:2317212 |
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G
|
LOC101970767
|
steroid 17-alpha-hydroxylase/17,20 lyase
|
susceptibility
|
ISO
|
DNA:transition:5' utr:-34T>C rs743572 (human)
|
RGD |
PMID:16381022 |
RGD:2317619 |
NCBI chrNW_004936600:3,097,620...3,102,713
Ensembl chrNW_004936600:3,097,638...3,102,713
|
|
G
|
Lrp1b
|
LDL receptor related protein 1B
|
ameliorates
|
ISO
|
DNA:mutations:multiple: (human)
|
RGD |
PMID:32898339 |
RGD:150429787 |
NCBI chrNW_004936469:35,000,773...36,160,216
Ensembl chrNW_004936469:35,203,594...36,159,283
|
|
G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
PMID:15520168 PMID:15608678 PMID:15930273 PMID:17673550 PMID:21078999 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23946963 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26627007 PMID:26637981 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:37712948 More...
|
|
NCBI chrNW_004936566:3,924,013...3,951,052
Ensembl chrNW_004936566:3,923,934...3,951,073
|
|
G
|
Rbp4
|
retinol binding protein 4
|
disease_progression
|
ISO
|
associated with type 2 diabetes mellitus; protein:decreased expression:blood serum (human)
|
RGD |
PMID:37273108 |
RGD:329849105 |
NCBI chrNW_004936601:1,401,215...1,410,195
Ensembl chrNW_004936601:1,402,691...1,410,208
|
|
G
|
Rictor
|
RPTOR independent companion of MTOR complex 2
|
|
ISO
|
DNA:CNV, amplification:exon (human)
|
RGD |
PMID:24508317 |
RGD:152995522 |
NCBI chrNW_004936518:3,198,312...3,314,393
Ensembl chrNW_004936518:3,198,337...3,310,000
|
|
G
|
Smad4
|
SMAD family member 4
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
PMID:10479724 PMID:10764709 PMID:16152648 PMID:16436638 PMID:21465659 PMID:22810475 PMID:23239472 PMID:25931195 PMID:26467025 PMID:26689913 PMID:28492532 PMID:30851333 PMID:31949278 PMID:32561076 PMID:32719554 PMID:34393517 PMID:35982159 PMID:36158166 PMID:36451132 PMID:37319387 More...
|
|
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G
|
Tp53
|
tumor protein p53
|
|
ISO
|
ClinVar Annotator: match by term: Gallbladder cancer
|
ClinVar |
PMID:1631137 PMID:1978757 PMID:7478555 PMID:7791795 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8276238 PMID:8425176 PMID:8527048 PMID:8688334 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11370630 PMID:11782540 PMID:11793474 PMID:12406399 PMID:12506399 PMID:12826609 PMID:14673037 PMID:14743206 PMID:15925506 PMID:15993273 PMID:16199547 PMID:16818505 PMID:16861262 PMID:16969106 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17881637 PMID:18978813 PMID:19378321 PMID:19556618 PMID:19711436 PMID:19714490 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20436704 PMID:20522432 PMID:21059199 PMID:21305319 PMID:21343334 PMID:21519010 PMID:21601526 PMID:21665182 PMID:21761402 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24382691 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25293557 PMID:25544776 PMID:25587027 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26718964 PMID:26787237 PMID:26911350 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28160093 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29324801 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30720243 PMID:31105275 PMID:31127191 PMID:31742824 PMID:31775759 PMID:32187361 PMID:32817165 PMID:33300245 PMID:33471991 PMID:34240179 PMID:36988593 More...
|
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G
|
Xrcc1
|
X-ray repair cross complementing 1
|
susceptibility
|
ISO
|
DNA:polymorphisms: :p.R194W, p.R399Q (human)
|
RGD |
PMID:19266243 |
RGD:2317128 |
NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777
|
|
|
G
|
Abo
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
|
ISO
|
|
RGD |
PMID:7795450 |
RGD:2317512 |
NCBI chrNW_004936570:1,315,192...1,322,719
|
|
G
|
Actr3
|
actin related protein 3
|
severity
|
ISO
|
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
|
RGD |
PMID:23320827 |
RGD:11571623 |
NCBI chrNW_004936469:55,639,345...55,699,330
Ensembl chrNW_004936469:55,639,068...55,699,640
|
|
G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
severity
|
ISO
|
|
RGD |
PMID:21545221 |
RGD:9684943 |
NCBI chrNW_004936491:13,288,986...13,516,878
Ensembl chrNW_004936491:13,288,717...13,516,984
|
|
G
|
Birc3
|
baculoviral IAP repeat containing 3
|
exacerbates
|
ISO
|
mRNA:increased expression:gall bladder (human)
|
RGD |
PMID:28295868 |
RGD:153297817 |
NCBI chrNW_004936551:5,544,047...5,556,550
Ensembl chrNW_004936551:5,544,065...5,556,555
|
|
G
|
Cfl1
|
cofilin 1
|
severity
|
ISO
|
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
|
RGD |
PMID:23320827 |
RGD:11571623 |
NCBI chrNW_004936599:3,678,724...3,682,314
Ensembl chrNW_004936599:3,677,804...3,682,307
|
|
G
|
Clptm1l
|
CLPTM1 like
|
susceptibility
|
ISO
|
DNA:SNP, haplotype: :rs401681(human)
|
RGD |
PMID:29450669 |
RGD:150530629 |
NCBI chrNW_004936815:421,996...445,577
Ensembl chrNW_004936815:428,920...445,750
|
|
G
|
Gpx3
|
glutathione peroxidase 3
|
severity
|
ISO
|
protein:decreased expression:gallbladder (human)
|
RGD |
PMID:24167362 |
RGD:151665515 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G
|
Il10
|
interleukin 10
|
susceptibility
|
ISO
|
associated with Cholelithiasis
|
RGD |
PMID:19065724 |
RGD:2317654 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G
|
Mtus1
|
microtubule associated scaffold protein 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:31882471 |
RGD:25330344 |
NCBI chrNW_004936614:242,710...387,541
Ensembl chrNW_004936614:240,113...387,730
|
|
G
|
Ptch1
|
patched 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:22407314 |
RGD:150523794 |
NCBI chrNW_004936626:4,241,993...4,301,919
Ensembl chrNW_004936626:4,241,908...4,309,476
|
|
G
|
Rac1
|
Rac family small GTPase 1
|
exacerbates
|
ISO
|
protein:increased expression:gallbladder (human)
|
RGD |
PMID:21853342 |
RGD:155230819 |
NCBI chrNW_004936750:107,689...122,679
Ensembl chrNW_004936750:107,689...122,676
|
|
G
|
Tert
|
telomerase reverse transcriptase
|
susceptibility
|
ISO
|
DNA:SNP, haplotype: :rs2736100(human)
|
RGD |
PMID:29450669 |
RGD:150530629 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G
|
Tgfa
|
transforming growth factor alpha
|
|
ISO
|
|
RGD |
PMID:9542514 |
RGD:2317470 |
NCBI chrNW_004936491:14,659,089...14,758,614
Ensembl chrNW_004936491:14,657,100...14,758,848
|
|
G
|
Tjp1
|
tight junction protein 1
|
|
ISO
|
protein:decreased expression:gallbladder
|
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chrNW_004936483:1,814,870...2,045,802
Ensembl chrNW_004936483:1,814,894...2,030,946
|
|
G
|
Tymp
|
thymidine phosphorylase
|
disease_progression
|
ISO
|
|
RGD |
PMID:18946757 |
RGD:2325157 |
NCBI chrNW_004936629:315,609...320,356
Ensembl chrNW_004936629:315,610...319,076
|
|
G
|
Ubr5
|
ubiquitin protein ligase E3 component n-recognin 5
|
ameliorates
|
ISO
|
human cell line in a mouse model
|
RGD |
PMID:30775814 |
RGD:151665192 |
NCBI chrNW_004936470:41,222,782...41,345,755
Ensembl chrNW_004936470:41,252,951...41,344,134
|
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
|
ISO
|
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma
|
ClinVar |
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
|
|
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G
|
Arid1a
|
AT-rich interaction domain 1A
|
disease_progression exacerbates
|
ISO
|
protein:decreased expression:intrahepatic bile duct (human) mRNA,protein:decreased expression:intrahepatic bile duct (human)
|
RGD |
PMID:27433094 PMID:30849962 PMID:31665232 |
RGD:126775257 RGD:126781775 RGD:14974231 |
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:27864835 |
RGD:150340628 |
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G
|
Becn1
|
beclin 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:30849962 |
RGD:14974231 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
severity
|
ISO
|
DNA:missense mutation:cds:p.V600E (human)
|
RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G
|
Fas
|
Fas cell surface death receptor
|
disease_progression
|
ISO
|
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004936735:209,369...234,582
|
|
G
|
Faslg
|
Fas ligand
|
severity
|
ISO
|
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G
|
Foxp3
|
forkhead box P3
|
|
ISO
|
DNA:hypomethylation:liver
|
RGD |
PMID:24291052 |
RGD:38599002 |
NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308
|
|
G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
disease_progression
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936835:316,767...321,999
Ensembl chrNW_004936835:316,767...321,990
|
|
G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
disease_progression
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936476:15,830,459...15,836,994
Ensembl chrNW_004936476:15,830,459...15,835,535
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
no_association
|
ISO
|
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human)
|
RGD |
PMID:26245674 |
RGD:14974229 |
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
disease_progression
|
ISO
|
DNA:mutations: : mRNA:decreased expression:liver (mouse)
|
RGD |
PMID:22824796 PMID:32463951 |
RGD:149735894 RGD:14985256 |
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G
|
Kdm5c
|
lysine demethylase 5C
|
exacerbates
|
ISO
|
protein:decreased expression:bile duct (human)
|
RGD |
PMID:32714863 |
RGD:151361175 |
NCBI chrNW_004936751:159,628...204,136
Ensembl chrNW_004936751:167,920...203,966
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
disease_progression
|
ISO
|
DNA:mutations::
|
RGD MouseDO |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G
|
Lcn2
|
lipocalin 2
|
treatment
|
ISO
|
Protein:increased expression:bile duct
|
RGD |
PMID:24939880 |
RGD:126790491 |
NCBI chrNW_004936487:15,721,752...15,725,396
Ensembl chrNW_004936487:15,721,684...15,728,221
|
|
G
|
LOC101962705
|
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1
|
disease_progression
|
ISO
|
protein:increased expression:intrahepatic bile duct (human)
|
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004936637:985,706...1,154,670
Ensembl chrNW_004936637:560,298...1,151,850
|
|
G
|
Lrp1b
|
LDL receptor related protein 1B
|
exacerbates
|
ISO
|
DNA:mutations:multiple: (human)
|
RGD |
PMID:33014052 |
RGD:150429786 |
NCBI chrNW_004936469:35,000,773...36,160,216
Ensembl chrNW_004936469:35,203,594...36,159,283
|
|
G
|
Pbrm1
|
polybromo 1
|
disease_progression
|
ISO
|
protein:increased expression:intrahepatic bile duct (human)
|
RGD |
PMID:27864835 PMID:30377796 |
RGD:150340628 RGD:152998946 |
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
disease_progression
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G
|
Rnf43
|
ring finger protein 43
|
exacerbates
|
ISO
|
mRNA, protein:decreased expression:liver, bile duct epithelium (human)
|
RGD |
PMID:26980022 |
RGD:151361125 |
NCBI chrNW_004936490:4,660,904...4,742,669
Ensembl chrNW_004936490:4,683,725...4,741,828
|
|
G
|
Smad4
|
SMAD family member 4
|
disease_progression
|
ISO
|
mRNA,protein:decreased expression:intrahepatic bile duct
|
RGD |
PMID:16917866 PMID:23981608 |
RGD:18936999 RGD:21066336 |
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G
|
Tep1
|
telomerase associated protein 1
|
|
ISO
|
mRNA:increased expression:hepatocyte,biliary epithelium.
|
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chrNW_004936877:575,264...613,965
Ensembl chrNW_004936877:575,037...641,642
|
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
|
ISO
|
ClinVar Annotator: match by term: Klatskin tumor
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G
|
Arid1a
|
AT-rich interaction domain 1A
|
disease_progression
|
ISO
|
DNA:deletions
|
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G
|
Gata6
|
GATA binding protein 6
|
sexual_dimorphism
|
ISO
|
DNA:mutations
|
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936550:1,814,336...1,844,399
Ensembl chrNW_004936550:1,814,336...1,844,399
|
|
G
|
Kmt2c
|
lysine methyltransferase 2C
|
onset
|
ISO
|
DNA:mutations
|
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936527:7,310,885...7,508,032
Ensembl chrNW_004936527:7,312,721...7,506,365
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
disease_progression
|
ISO
|
DNA:mutations
|
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G
|
Prex2
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
|
sexual_dimorphism
|
ISO
|
DNA:substitutions, insertion/deletions: (human)
|
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936496:6,005,410...6,284,332
Ensembl chrNW_004936496:6,008,277...6,284,346
|
|